Clincosm LogoSign in Get a demo

Hospice Quality Score Assessment Post Pharmacist Intervention

Sponsor
Tabula Rasa HealthCare (Industry)
Overall Status
Active, not recruiting
CT.gov ID
NCT04361669
Collaborator
(none)
100
Enrollment
1
Location
35.3
Anticipated Duration (Months)
2.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Condition or Disease Intervention/Treatment Phase
  • Other: Medication safety review

Detailed Description

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores. These scores are calculated by the hospice using existing patient satisfaction survey scores (HCAHPS). The institution quantifies their compliance with national quality metrics (NQF) and reports this existing data to the pharmacist providing counseling services to their patients. The pharmacist assesses for areas for improvement and provides additional counseling services to improve the continuity and quality of care. The pilot program is scheduled to launch April 2020 and the researchers will look to assess for changes in the NQF scores, HCAHPS scores, and time for their partnering pharmacy to refill the first set of prescriptions.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Assessing the Impact of Pharmacist Interventions on Hospice Quality Scores
Actual Study Start Date :
Apr 22, 2020
Anticipated Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Intervention

Patients that receive pharmacist-delivered services in the pilot program

Other: Medication safety review
Implementation of a medication safety review using a clinical decision support system
Control

Patients that do not receive pharmacist-delivered services in the pilot program

Other: Medication safety review
Implementation of a medication safety review using a clinical decision support system

Outcome Measures

Primary Outcome Measures

  1. National Quality Forum Score [6 months]

    Performance metric used by hospice. Scale 0 - 100 (0=min; 100-high)

  2. Consumer Assessment of Healthcare Providers and Systems [6 months]

    Performance metric used by hospice (0=min; 100-high)

  3. Time to refill [6 months]

    Time to refill prescription from hospice organization (0=min; 100-high)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 88 Years
Sexes Eligible for Study:
All
Inclusion Criteria:

Adult patients who were referred to hospice by a healthcare provider

Exclusion Criteria:

Patients 89 years or older

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tabula Rasa HealthCare Tucson Arizona United States 85701

Sponsors and Collaborators

  • Tabula Rasa HealthCare

Investigators

  • Principal Investigator: Jennifer Bingham, PharmD, Tabula Rasa HealthCare

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tabula Rasa HealthCare
ClinicalTrials.gov Identifier:
NCT04361669
Other Study ID Numbers:
  • TRHC_RD_Hospice_2020
First Posted:
Apr 24, 2020
Last Update Posted:
Apr 1, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Tabula Rasa HealthCare
National Quality Forum Score
HCAHPS
Medication refill
Number medications
Additional relevant MeSH terms:
Respiration Disorders
Respiratory Tract Diseases
Nervous System Diseases
Cardiovascular Diseases

Study Results

No Results Posted as of Apr 1, 2022